Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16461044rdf:typepubmed:Citationlld:pubmed
pubmed-article:16461044lifeskim:mentionsumls-concept:C0080202lld:lifeskim
pubmed-article:16461044lifeskim:mentionsumls-concept:C0038257lld:lifeskim
pubmed-article:16461044lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:16461044pubmed:issue4lld:pubmed
pubmed-article:16461044pubmed:dateCreated2006-2-7lld:pubmed
pubmed-article:16461044pubmed:abstractTextWe sought to investigate the effects of 2 different coronary drug-eluting stents on the distribution of central or effector memory T cells circulating in the coronary sinus of patients with coronary artery disease who underwent percutaneous coronary revascularization. We randomly assigned 43 patients (mean age 65.4 +/- 4.3 years; 34 men) presenting with stable coronary disease and angiographically proved stenosis of the left anterior descending artery to treatment with sirolimus- or paclitaxel-eluting stents. Heparinized blood samples were obtained from the coronary sinus before and 20 minutes after stent implantation. Analysis of surface phenotype was performed by 4-color flow cytometry, and data are expressed as the percentage of positive cells. The percentages of CD8+ and CD4+ effector memory T cells, as defined by the CD3+CD45RO+CD27- phenotype, were significantly reduced in patients who received a sirolimus-eluting stent compared with the basal values. Conversely, the percentages of CD8+, but not CD4+, central memory T cells (CD3+CD45RO+CD27+) were increased in the same treatment group after the revascularization procedure. No changes in the percentages of memory T-cell populations in the paclitaxel-eluting stent group were observed. These findings show that sirolimus-eluting stents rapidly induced a redistribution of memory T lymphocytes, with a significant decrease of proinflammatory effector memory T cells circulating within the coronary sinus.lld:pubmed
pubmed-article:16461044pubmed:languageenglld:pubmed
pubmed-article:16461044pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16461044pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16461044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16461044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16461044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16461044pubmed:statusMEDLINElld:pubmed
pubmed-article:16461044pubmed:monthFeblld:pubmed
pubmed-article:16461044pubmed:issn0002-9149lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:FedeleFrances...lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:ParoliMarinoMlld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:SardellaGenna...lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:16461044pubmed:authorpubmed-author:ContiGiuliaGlld:pubmed
pubmed-article:16461044pubmed:issnTypePrintlld:pubmed
pubmed-article:16461044pubmed:day15lld:pubmed
pubmed-article:16461044pubmed:volume97lld:pubmed
pubmed-article:16461044pubmed:ownerNLMlld:pubmed
pubmed-article:16461044pubmed:authorsCompleteYlld:pubmed
pubmed-article:16461044pubmed:pagination494-8lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:meshHeadingpubmed-meshheading:16461044...lld:pubmed
pubmed-article:16461044pubmed:year2006lld:pubmed
pubmed-article:16461044pubmed:articleTitleComparison between sirolimus- and paclitaxel-eluting stent in T-cell subsets redistribution.lld:pubmed
pubmed-article:16461044pubmed:affiliationDipartimento di Scienze Cardiovascolari e Respiratorie, Università La Sapienza, Rome, Italy. rino.sardella@uniroma1.itlld:pubmed
pubmed-article:16461044pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16461044pubmed:publicationTypeRandomized Controlled Triallld:pubmed